indian pharma regulation, a shift in paradrigm
TRANSCRIPT
![Page 1: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/1.jpg)
Indian Pharmaceutical RegulationsA current regulatory overview
Prepared by: Sambhujyoti Das
![Page 2: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/2.jpg)
2
Indian Pharmaceutical Sector – An Overview
One of the high performing knowledge based segments of the manufacturing sector.• The ‘organised’ sector of India’s pharmaceutical industry consists of about 300 companies.
• The total sector is estimated at nearly 20,000 businesses.
• 400 + bulk drugs are produced.
• Producing high quality generic medicines that are sold around the world.
• Supplying 20% (value wise) of the global market for generic medicines.
• Exporting medicine to over 200 countries.
• Total review around US$ 20 bn +.
• Compound annual growth rate of 20 percent.
![Page 3: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/3.jpg)
3
+
Regulatory Framework
As per Drugs & Cosmetic Act 1940.
![Page 4: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/4.jpg)
4
Proposed New Drug Regulatory System
• Formation of Central Drug Authority (CDA) in January 2007.
• The organisational structure of CDA would be similar to US FDA.
• It would be strong, well equipped, empowered, independent and professionally managed.
• It would facilitate upgradation of the national drugs regulator, uniformity of licencing and
improvement in drug regulations.
• Strict enforcement of GMP standards to builds up trust of its clients and the obligation on
the regulatory bodies.
• Training and technical capacity building and provide necessary know how to help
manufacturer with GMP compliance.
• Focus on inspection, pharmacovigilance and drug enforcement activities.
![Page 5: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/5.jpg)
5
Proposed New Drug Regulatory System
CDA(Central Drug
Administration)
CDSCO(Central Drug Standard Control
Organization)
SDRA(State Drug Regulatory Agency)
Central independent body under Ministry of Health &
Family Welfare
Central body
State entity
![Page 6: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/6.jpg)
6
Roles and Responsibilities
![Page 7: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/7.jpg)
7
Regulatory Reforms
MANPOWER Creation of new
posts. Capability & skill
development through trainings.
Optimum utilization of current staff.
INFRASTRUCTURE Expansion of zonal &
sub zonal offices. Strengthening of
central & state drug testing labs.
Expansion of current pharmacovigilance programmes.
INSPECTIONS CDA grants Mfg. license.
Establish surveillance against suspected persons.
Strict adherence to scheduled standards.
![Page 8: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/8.jpg)
8
Regulatory Reforms
FINANCE
Additional fund to CDA INDEPENDENT
REGULATOR Efficient, strong & effective CDA.
Autonomous organization under DCGI.TRANSPARENCY & 3RD
PARTY OVERSIGHT Traceable distribution
channel. Awareness program to
customers. Drug information on
internet. Press release against
noncomplying products and organizations.
ADE reporting through internet.
![Page 9: Indian pharma regulation, a shift in paradrigm](https://reader035.vdocuments.us/reader035/viewer/2022070510/58a767301a28ab217e8b6d19/html5/thumbnails/9.jpg)
Questions and discussion
THANK YOU